Multicentre study shows systemic therapy preferences in patients with psoriasis, suggesting specific administration methods.
Most topically treated patients with moderate-to-severe AD or PSO desire systemic therapy, with distinct disease-specific administration preferences.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: